HEADER TRANSCRIPTION REGULATOR/INHIBITOR 29-MAY-17 5VZS TITLE BRD4-BD1 IN COMPLEX WITH CPD19 (3-(7-(DIFLUOROMETHYL)-6-(1-METHYL-1H- TITLE 2 PYRAZOL-4-YL)-3,4-DIHYDROQUINOLIN-1(2H)-YL)-N-METHYL-1-(TETRAHYDRO- TITLE 3 2H-PYRAN-4-YL)-1,4,6,7-TETRAHYDRO-5H-PYRAZOLO[4,3-C]PYRIDINE-5- TITLE 4 CARBOXAMIDE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: BROMODOMAIN-CONTAINING PROTEIN 4; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BRD4 BROMODOMAIN-1, UNP RESIDUES 42-168; COMPND 5 SYNONYM: PROTEIN HUNK1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BRD4, HUNK1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS BRD4, BROMODOMAIN, SMALL MOLECULE INHIBITOR, TRANSCRIPTION REGULATOR- KEYWDS 2 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.M.MURRAY REVDAT 2 04-OCT-23 5VZS 1 REMARK REVDAT 1 30-MAY-18 5VZS 0 JRNL AUTH J.M.MURRAY JRNL TITL GNE-781, A HIGHLY ADVANCED POTENT AND SELECTIVE BROMODOMAIN JRNL TITL 2 INHIBITOR OF CBP/P300 JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.71 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX DEV_2747 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.71 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.23 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.970 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.2 REMARK 3 NUMBER OF REFLECTIONS : 28201 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.194 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.226 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.060 REMARK 3 FREE R VALUE TEST SET COUNT : 1427 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 29.2315 - 3.6753 0.97 2717 154 0.1488 0.1822 REMARK 3 2 3.6753 - 2.9180 0.98 2742 176 0.1779 0.2175 REMARK 3 3 2.9180 - 2.5494 0.98 2755 129 0.2076 0.2399 REMARK 3 4 2.5494 - 2.3164 0.98 2729 154 0.2112 0.2425 REMARK 3 5 2.3164 - 2.1504 0.97 2767 114 0.2024 0.2389 REMARK 3 6 2.1504 - 2.0237 0.96 2746 138 0.2064 0.2590 REMARK 3 7 2.0237 - 1.9224 0.97 2681 164 0.2365 0.2706 REMARK 3 8 1.9224 - 1.8387 0.95 2672 149 0.2665 0.3172 REMARK 3 9 1.8387 - 1.7679 0.93 2602 129 0.2976 0.3429 REMARK 3 10 1.7679 - 1.7069 0.83 2363 120 0.3313 0.3645 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 30.350 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.97 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 33.16 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 2284 REMARK 3 ANGLE : 0.922 3114 REMARK 3 CHIRALITY : 0.048 321 REMARK 3 PLANARITY : 0.006 399 REMARK 3 DIHEDRAL : 12.755 1363 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): -1.5890 3.5262 31.0582 REMARK 3 T TENSOR REMARK 3 T11: 0.2028 T22: 0.2078 REMARK 3 T33: 0.2173 T12: -0.0068 REMARK 3 T13: -0.0170 T23: 0.0230 REMARK 3 L TENSOR REMARK 3 L11: 0.7687 L22: 0.7252 REMARK 3 L33: 2.0186 L12: -0.6988 REMARK 3 L13: -0.9369 L23: 1.2064 REMARK 3 S TENSOR REMARK 3 S11: -0.0407 S12: 0.0869 S13: -0.0365 REMARK 3 S21: 0.0092 S22: -0.0796 S23: 0.0285 REMARK 3 S31: 0.0440 S32: -0.1869 S33: 0.0001 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5VZS COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-JUN-17. REMARK 100 THE DEPOSITION ID IS D_1000228204. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-NOV-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17B1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.979 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 28278 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.700 REMARK 200 RESOLUTION RANGE LOW (A) : 29.227 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.1 REMARK 200 DATA REDUNDANCY : 3.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 89.9 REMARK 200 DATA REDUNDANCY IN SHELL : 3.10 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MIR REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDBID 5KU3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 34.55 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.88 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 0.2 M SODIUM FORMATE, REMARK 280 VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 12 REMARK 465 HIS A 13 REMARK 465 HIS A 14 REMARK 465 HIS A 15 REMARK 465 HIS A 16 REMARK 465 HIS A 17 REMARK 465 HIS A 18 REMARK 465 GLY A 19 REMARK 465 SER A 20 REMARK 465 LEU A 21 REMARK 465 VAL A 22 REMARK 465 PRO A 23 REMARK 465 ARG A 24 REMARK 465 GLY A 25 REMARK 465 SER A 26 REMARK 465 MET A 27 REMARK 465 ASP A 28 REMARK 465 TYR A 29 REMARK 465 LYS A 30 REMARK 465 ASP A 31 REMARK 465 ASP A 32 REMARK 465 ASP A 33 REMARK 465 ASP A 34 REMARK 465 LYS A 35 REMARK 465 GLU A 36 REMARK 465 ASN A 37 REMARK 465 LEU A 38 REMARK 465 TYR A 39 REMARK 465 PHE A 40 REMARK 465 GLN A 41 REMARK 465 MET B 12 REMARK 465 HIS B 13 REMARK 465 HIS B 14 REMARK 465 HIS B 15 REMARK 465 HIS B 16 REMARK 465 HIS B 17 REMARK 465 HIS B 18 REMARK 465 GLY B 19 REMARK 465 SER B 20 REMARK 465 LEU B 21 REMARK 465 VAL B 22 REMARK 465 PRO B 23 REMARK 465 ARG B 24 REMARK 465 GLY B 25 REMARK 465 SER B 26 REMARK 465 MET B 27 REMARK 465 ASP B 28 REMARK 465 TYR B 29 REMARK 465 LYS B 30 REMARK 465 ASP B 31 REMARK 465 ASP B 32 REMARK 465 ASP B 33 REMARK 465 ASP B 34 REMARK 465 LYS B 35 REMARK 465 GLU B 36 REMARK 465 ASN B 37 REMARK 465 LEU B 38 REMARK 465 TYR B 39 REMARK 465 PHE B 40 REMARK 465 GLN B 41 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 59 CD REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH B 363 O HOH B 384 2.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 357 DISTANCE = 6.56 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO A 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9U4 A 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EDO B 202 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 9U4 B 203 DBREF 5VZS A 42 168 UNP O60885 BRD4_HUMAN 42 168 DBREF 5VZS B 42 168 UNP O60885 BRD4_HUMAN 42 168 SEQADV 5VZS MET A 12 UNP O60885 INITIATING METHIONINE SEQADV 5VZS HIS A 13 UNP O60885 EXPRESSION TAG SEQADV 5VZS HIS A 14 UNP O60885 EXPRESSION TAG SEQADV 5VZS HIS A 15 UNP O60885 EXPRESSION TAG SEQADV 5VZS HIS A 16 UNP O60885 EXPRESSION TAG SEQADV 5VZS HIS A 17 UNP O60885 EXPRESSION TAG SEQADV 5VZS HIS A 18 UNP O60885 EXPRESSION TAG SEQADV 5VZS GLY A 19 UNP O60885 EXPRESSION TAG SEQADV 5VZS SER A 20 UNP O60885 EXPRESSION TAG SEQADV 5VZS LEU A 21 UNP O60885 EXPRESSION TAG SEQADV 5VZS VAL A 22 UNP O60885 EXPRESSION TAG SEQADV 5VZS PRO A 23 UNP O60885 EXPRESSION TAG SEQADV 5VZS ARG A 24 UNP O60885 EXPRESSION TAG SEQADV 5VZS GLY A 25 UNP O60885 EXPRESSION TAG SEQADV 5VZS SER A 26 UNP O60885 EXPRESSION TAG SEQADV 5VZS MET A 27 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASP A 28 UNP O60885 EXPRESSION TAG SEQADV 5VZS TYR A 29 UNP O60885 EXPRESSION TAG SEQADV 5VZS LYS A 30 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASP A 31 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASP A 32 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASP A 33 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASP A 34 UNP O60885 EXPRESSION TAG SEQADV 5VZS LYS A 35 UNP O60885 EXPRESSION TAG SEQADV 5VZS GLU A 36 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASN A 37 UNP O60885 EXPRESSION TAG SEQADV 5VZS LEU A 38 UNP O60885 EXPRESSION TAG SEQADV 5VZS TYR A 39 UNP O60885 EXPRESSION TAG SEQADV 5VZS PHE A 40 UNP O60885 EXPRESSION TAG SEQADV 5VZS GLN A 41 UNP O60885 EXPRESSION TAG SEQADV 5VZS MET B 12 UNP O60885 INITIATING METHIONINE SEQADV 5VZS HIS B 13 UNP O60885 EXPRESSION TAG SEQADV 5VZS HIS B 14 UNP O60885 EXPRESSION TAG SEQADV 5VZS HIS B 15 UNP O60885 EXPRESSION TAG SEQADV 5VZS HIS B 16 UNP O60885 EXPRESSION TAG SEQADV 5VZS HIS B 17 UNP O60885 EXPRESSION TAG SEQADV 5VZS HIS B 18 UNP O60885 EXPRESSION TAG SEQADV 5VZS GLY B 19 UNP O60885 EXPRESSION TAG SEQADV 5VZS SER B 20 UNP O60885 EXPRESSION TAG SEQADV 5VZS LEU B 21 UNP O60885 EXPRESSION TAG SEQADV 5VZS VAL B 22 UNP O60885 EXPRESSION TAG SEQADV 5VZS PRO B 23 UNP O60885 EXPRESSION TAG SEQADV 5VZS ARG B 24 UNP O60885 EXPRESSION TAG SEQADV 5VZS GLY B 25 UNP O60885 EXPRESSION TAG SEQADV 5VZS SER B 26 UNP O60885 EXPRESSION TAG SEQADV 5VZS MET B 27 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASP B 28 UNP O60885 EXPRESSION TAG SEQADV 5VZS TYR B 29 UNP O60885 EXPRESSION TAG SEQADV 5VZS LYS B 30 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASP B 31 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASP B 32 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASP B 33 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASP B 34 UNP O60885 EXPRESSION TAG SEQADV 5VZS LYS B 35 UNP O60885 EXPRESSION TAG SEQADV 5VZS GLU B 36 UNP O60885 EXPRESSION TAG SEQADV 5VZS ASN B 37 UNP O60885 EXPRESSION TAG SEQADV 5VZS LEU B 38 UNP O60885 EXPRESSION TAG SEQADV 5VZS TYR B 39 UNP O60885 EXPRESSION TAG SEQADV 5VZS PHE B 40 UNP O60885 EXPRESSION TAG SEQADV 5VZS GLN B 41 UNP O60885 EXPRESSION TAG SEQRES 1 A 157 MET HIS HIS HIS HIS HIS HIS GLY SER LEU VAL PRO ARG SEQRES 2 A 157 GLY SER MET ASP TYR LYS ASP ASP ASP ASP LYS GLU ASN SEQRES 3 A 157 LEU TYR PHE GLN SER THR ASN PRO PRO PRO PRO GLU THR SEQRES 4 A 157 SER ASN PRO ASN LYS PRO LYS ARG GLN THR ASN GLN LEU SEQRES 5 A 157 GLN TYR LEU LEU ARG VAL VAL LEU LYS THR LEU TRP LYS SEQRES 6 A 157 HIS GLN PHE ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA SEQRES 7 A 157 VAL LYS LEU ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS SEQRES 8 A 157 THR PRO MET ASP MET GLY THR ILE LYS LYS ARG LEU GLU SEQRES 9 A 157 ASN ASN TYR TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP SEQRES 10 A 157 PHE ASN THR MET PHE THR ASN CYS TYR ILE TYR ASN LYS SEQRES 11 A 157 PRO GLY ASP ASP ILE VAL LEU MET ALA GLU ALA LEU GLU SEQRES 12 A 157 LYS LEU PHE LEU GLN LYS ILE ASN GLU LEU PRO THR GLU SEQRES 13 A 157 GLU SEQRES 1 B 157 MET HIS HIS HIS HIS HIS HIS GLY SER LEU VAL PRO ARG SEQRES 2 B 157 GLY SER MET ASP TYR LYS ASP ASP ASP ASP LYS GLU ASN SEQRES 3 B 157 LEU TYR PHE GLN SER THR ASN PRO PRO PRO PRO GLU THR SEQRES 4 B 157 SER ASN PRO ASN LYS PRO LYS ARG GLN THR ASN GLN LEU SEQRES 5 B 157 GLN TYR LEU LEU ARG VAL VAL LEU LYS THR LEU TRP LYS SEQRES 6 B 157 HIS GLN PHE ALA TRP PRO PHE GLN GLN PRO VAL ASP ALA SEQRES 7 B 157 VAL LYS LEU ASN LEU PRO ASP TYR TYR LYS ILE ILE LYS SEQRES 8 B 157 THR PRO MET ASP MET GLY THR ILE LYS LYS ARG LEU GLU SEQRES 9 B 157 ASN ASN TYR TYR TRP ASN ALA GLN GLU CYS ILE GLN ASP SEQRES 10 B 157 PHE ASN THR MET PHE THR ASN CYS TYR ILE TYR ASN LYS SEQRES 11 B 157 PRO GLY ASP ASP ILE VAL LEU MET ALA GLU ALA LEU GLU SEQRES 12 B 157 LYS LEU PHE LEU GLN LYS ILE ASN GLU LEU PRO THR GLU SEQRES 13 B 157 GLU HET EDO A 201 4 HET 9U4 A 202 38 HET EDO B 201 4 HET EDO B 202 4 HET 9U4 B 203 38 HETNAM EDO 1,2-ETHANEDIOL HETNAM 9U4 3-[7-(DIFLUOROMETHYL)-6-(1-METHYL-1H-PYRAZOL-4-YL)-3,4- HETNAM 2 9U4 DIHYDROQUINOLIN-1(2H)-YL]-N-METHYL-1-(OXAN-4-YL)-1,4, HETNAM 3 9U4 6,7-TETRAHYDRO-5H-PYRAZOLO[4,3-C]PYRIDINE-5- HETNAM 4 9U4 CARBOXAMIDE HETSYN EDO ETHYLENE GLYCOL FORMUL 3 EDO 3(C2 H6 O2) FORMUL 4 9U4 2(C27 H33 F2 N7 O2) FORMUL 8 HOH *142(H2 O) HELIX 1 AA1 THR A 60 VAL A 69 1 10 HELIX 2 AA2 VAL A 69 LYS A 76 1 8 HELIX 3 AA3 ALA A 80 GLN A 84 5 5 HELIX 4 AA4 ASP A 88 ASN A 93 1 6 HELIX 5 AA5 ASP A 96 ILE A 101 1 6 HELIX 6 AA6 ASP A 106 ASN A 116 1 11 HELIX 7 AA7 ASN A 121 ASN A 140 1 20 HELIX 8 AA8 ASP A 144 ASN A 162 1 19 HELIX 9 AA9 THR B 60 VAL B 69 1 10 HELIX 10 AB1 VAL B 69 LYS B 76 1 8 HELIX 11 AB2 HIS B 77 GLN B 84 5 8 HELIX 12 AB3 ASP B 88 ASN B 93 1 6 HELIX 13 AB4 ASP B 96 ILE B 101 1 6 HELIX 14 AB5 ASP B 106 ASN B 116 1 11 HELIX 15 AB6 ASN B 121 ASN B 140 1 20 HELIX 16 AB7 ASP B 144 ASN B 162 1 19 SITE 1 AC1 5 ILE A 100 ILE A 101 LYS A 102 THR A 103 SITE 2 AC1 5 ASN A 135 SITE 1 AC2 10 TRP A 81 PHE A 83 LEU A 92 LEU A 94 SITE 2 AC2 10 TYR A 139 ASN A 140 HOH A 304 HOH A 326 SITE 3 AC2 10 GLN B 78 9U4 B 203 SITE 1 AC3 5 ILE B 100 ILE B 101 LYS B 102 THR B 103 SITE 2 AC3 5 ASN B 135 SITE 1 AC4 4 TRP B 75 LYS B 76 HIS B 77 GLN B 84 SITE 1 AC5 9 9U4 A 202 GLN B 78 TRP B 81 PRO B 82 SITE 2 AC5 9 PHE B 83 ASN B 140 MET B 149 HOH B 307 SITE 3 AC5 9 HOH B 330 CRYST1 29.986 41.878 59.895 102.08 106.79 89.36 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.033349 -0.000374 0.010219 0.00000 SCALE2 0.000000 0.023880 0.005263 0.00000 SCALE3 0.000000 0.000000 0.017857 0.00000